Asia Pacific Genotyping Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis – by Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption / MALDI-TOF, and Other Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), End user (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users)

No. of Pages: 160
Report Code: BMIRE00025968
Category: Life Sciences
Asia Pacific Genotyping Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Genotyping Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Genotyping Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Genotyping Market Regional Analysis

6.2 Asia Pacific Genotyping Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Genotyping Market Forecast Analysis

7. Asia Pacific Genotyping Market Analysis – by Product Type

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Reagents and Kits
  • 7.2.1 Overview
  • 7.2.2 Reagents and Kits: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Bioinformatics
  • 7.3.1 Overview
  • 7.3.2 Bioinformatics: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Genotyping Services
  • 7.4.1 Overview
  • 7.4.2 Genotyping Services: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Genotyping Market Analysis – by Technology

8.1 Microarray
  • 8.1.1 Overview
  • 8.1.2 Microarray: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Capillary Electrophoresis
  • 8.2.1 Overview
  • 8.2.2 Capillary Electrophoresis: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Sequencing
  • 8.3.1 Overview
  • 8.3.2 Sequencing: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Polymerase Chain Reaction
  • 8.4.1 Overview
  • 8.4.2 Polymerase Chain Reaction: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
  • 8.5.1 Overview
  • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Other Technologies
  • 8.6.1 Overview
  • 8.6.2 Other Technologies: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Genotyping Market Analysis – by Application

9.1 Pharmacogenomics
  • 9.1.1 Overview
  • 9.1.2 Pharmacogenomics: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
  • 9.2.1 Overview
  • 9.2.2 Diagnostics and Personalized Medicine: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Animal Genetics
  • 9.3.1 Overview
  • 9.3.2 Animal Genetics: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Agricultural Biotechnology
  • 9.4.1 Overview
  • 9.4.2 Agricultural Biotechnology: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Applications: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Genotyping Market Analysis – by End user

10.1 Pharmaceutical and Biopharmaceutical Companies
  • 10.1.1 Overview
  • 10.1.2 Pharmaceutical and Biopharmaceutical Companies: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Diagnostic and Research Laboratories
  • 10.2.1 Overview
  • 10.2.2 Diagnostic and Research Laboratories: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Academic Institutes
  • 10.3.1 Overview
  • 10.3.2 Academic Institutes: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Other End Users
  • 10.4.1 Overview
  • 10.4.2 Other End Users: Asia Pacific Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Genotyping Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific
  • 11.2.1 Asia Pacific Genotyping Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 11.2.1.1 Asia Pacific Genotyping Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 China: Asia Pacific Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 11.2.1.1.1 China: Asia Pacific Genotyping Market Breakdown, by Product Type
    • 11.2.1.1.2 China: Asia Pacific Genotyping Market Breakdown, by Technology
    • 11.2.1.1.3 China: Asia Pacific Genotyping Market Breakdown, by Application
    • 11.2.1.1.4 China: Asia Pacific Genotyping Market Breakdown, by End user
  • 11.2.1.2 India: Asia Pacific Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 11.2.1.2.1 India: Asia Pacific Genotyping Market Breakdown, by Product Type
    • 11.2.1.2.2 India: Asia Pacific Genotyping Market Breakdown, by Technology
    • 11.2.1.2.3 India: Asia Pacific Genotyping Market Breakdown, by Application
    • 11.2.1.2.4 India: Asia Pacific Genotyping Market Breakdown, by End user
  • 11.2.1.3 Japan: Asia Pacific Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 11.2.1.3.1 Japan: Asia Pacific Genotyping Market Breakdown, by Product Type
    • 11.2.1.3.2 Japan: Asia Pacific Genotyping Market Breakdown, by Technology
    • 11.2.1.3.3 Japan: Asia Pacific Genotyping Market Breakdown, by Application
    • 11.2.1.3.4 Japan: Asia Pacific Genotyping Market Breakdown, by End user
  • 11.2.1.4 Australia: Asia Pacific Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 11.2.1.4.1 Australia: Asia Pacific Genotyping Market Breakdown, by Product Type
    • 11.2.1.4.2 Australia: Asia Pacific Genotyping Market Breakdown, by Technology
    • 11.2.1.4.3 Australia: Asia Pacific Genotyping Market Breakdown, by Application
    • 11.2.1.4.4 Australia: Asia Pacific Genotyping Market Breakdown, by End user
  • 11.2.1.5 Rest of Asia-Pacific : Asia Pacific Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
    • 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Genotyping Market Breakdown, by Product Type
    • 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Genotyping Market Breakdown, by Technology
    • 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Genotyping Market Breakdown, by Application
    • 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Genotyping Market Breakdown, by End user

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Hoffmann-La Roche Ltd.
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 QIAGEN NV.
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Merck KGaA.
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 XCELRIS GENOMICS
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Thermo Fisher Scientific Inc.
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 BioTek Instruments, Inc.
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Illumina Inc.
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Danaher Corp.
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc.
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 GE HealthCare Technologies Inc.
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments
14.11 Standard BioTools Inc.
  • 14.11.1 Key Facts
  • 14.11.2 Business Description
  • 14.11.3 Products and Services
  • 14.11.4 Financial Overview
  • 14.11.5 SWOT Analysis
  • 14.11.6 Key Developments
14.12 Laboratory Corp of America Holdings.
  • 14.12.1 Key Facts
  • 14.12.2 Business Description
  • 14.12.3 Products and Services
  • 14.12.4 Financial Overview
  • 14.12.5 SWOT Analysis
  • 14.12.6 Key Developments
14.13 Beckman Coulter Inc.
  • 14.13.1 Key Facts
  • 14.13.2 Business Description
  • 14.13.3 Products and Services
  • 14.13.4 Financial Overview
  • 14.13.5 SWOT Analysis
  • 14.13.6 Key Developments
14.14 BGI.
  • 14.14.1 Key Facts
  • 14.14.2 Business Description
  • 14.14.3 Products and Services
  • 14.14.4 Financial Overview
  • 14.14.5 SWOT Analysis
  • 14.14.6 Key Developments
14.15 Takara Bio Inc.
  • 14.15.1 Key Facts
  • 14.15.2 Business Description
  • 14.15.3 Products and Services
  • 14.15.4 Financial Overview
  • 14.15.5 SWOT Analysis
  • 14.15.6 Key Developments
14.16 DiaSorin SpA.
  • 14.16.1 Key Facts
  • 14.16.2 Business Description
  • 14.16.3 Products and Services
  • 14.16.4 Financial Overview
  • 14.16.5 SWOT Analysis
  • 14.16.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Asia Pacific Genotyping Market

  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • XCELRIS GENOMICS
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Standard BioTools Inc.
  • Laboratory Corp of America Holdings.
  • Beckman Coulter Inc.
  • BGI.
  • Takara Bio Inc.
  • DiaSorin SpA.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)